Research Paper Volume 13, Issue 5 pp 7549—7569
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Figure 7. Forest plots showing that ginsenoside Rg1 decreased the content of (A) IL-1β and (B) IL-6 compared with a control.